{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T18:11:34Z","timestamp":1788286294171,"version":"build-2803163510"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalimaging.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Imaging"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.clinimag.2018.06.010","type":"journal-article","created":{"date-parts":[[2018,6,30]],"date-time":"2018-06-30T05:28:36Z","timestamp":1530336516000},"page":"347-351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Comparison of background parenchymal enhancement and fibroglandular density at breast magnetic resonance imaging between BRCA gene mutation carriers and non-carriers"],"prefix":"10.1016","volume":"51","author":[{"given":"Ahuva","family":"Grubstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yael","family":"Rapson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oshra","family":"Benzaquen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shira","family":"Rozenblatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itay","family":"Gadiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eli","family":"Atar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinat","family":"Yerushalmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matan J.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinimag.2018.06.010_bb0005","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1148\/radiology.203.1.9122382","article-title":"Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: normal contrast medium enhancement and cyclical-phase dependency","volume":"203","author":"Kuhl","year":"1997","journal-title":"Radiology"},{"key":"10.1016\/j.clinimag.2018.06.010_bb0010","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1148\/radiology.203.1.9122383","article-title":"Menstrual cycle and age: influence on parenchymal contrast medium enhancement in MR imaging of the breast","volume":"203","author":"Muller-Schimpfle","year":"1997","journal-title":"Radiology"},{"key":"10.1016\/j.clinimag.2018.06.010_bb0015","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1148\/radiol.13120121","article-title":"Pilot study of quantitative analysis of background enhancement on breast MR images: association with menstrual cycle and mammographic breast density","volume":"267","author":"Scaranelo","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.clinimag.2018.06.010_bb0020","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1075-122X.2005.21499.x","article-title":"Physiologic changes in breast magnetic resonance imaging during the menstrual cycle: perfusion imaging, signal enhancement, and influence of the T1 relaxation time of breast tissue","volume":"11","author":"Delille","year":"2005","journal-title":"Breast J"},{"key":"10.1016\/j.clinimag.2018.06.010_bb0025","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1007\/s00330-012-2553-8","article-title":"Impact of menopausal status on background parenchymal enhancement and fibroglandular tissue on breast MRI","volume":"22","author":"King","year":"2012","journal-title":"Eur Radiol"},{"key":"10.1016\/j.clinimag.2018.06.010_bb0030","doi-asserted-by":"crossref","first-page":"218","DOI":"10.2214\/AJR.10.4550","article-title":"Background parenchymal enhancement on baseline screening breast MRI: impact on biopsy rate and short-interval follow-up","volume":"196","author":"Hambly","year":"2011","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.clinimag.2018.06.010_bb0035","doi-asserted-by":"crossref","first-page":"W373","DOI":"10.2214\/AJR.10.6272","article-title":"Background parenchymal enhancement on breast MRI: impact on diagnostic performance","volume":"198","author":"DeMartini","year":"2012","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.clinimag.2018.06.010_bb0040","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1148\/radiol.11102156","article-title":"Background parenchymal enhancement at breast MR imaging and breast cancer risk","volume":"260","author":"King","year":"2011","journal-title":"Radiology"},{"key":"10.1016\/j.clinimag.2018.06.010_bb0045","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1158\/0008-5472.CAN-05-3368","article-title":"Mammographic density and breast cancer risk in BRCA1 and BRCA2 mutation carriers","volume":"66","author":"Mitchell","year":"2006","journal-title":"Cancer Res"},{"issue":"Suppl 8","key":"10.1016\/j.clinimag.2018.06.010_bb0050","doi-asserted-by":"crossref","first-page":"viii37","DOI":"10.1093\/annonc\/mdt310","article-title":"Mammographic density, MRI background parenchymal enhancement and breast cancer risk","volume":"24","author":"Pike","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clinimag.2018.06.010_bb0055","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/tbj.12002","article-title":"Impact of tamoxifen on amount of fibroglandular tissue, background parenchymal enhancement, and cysts on breast magnetic resonance imaging","volume":"18","author":"King","year":"2012","journal-title":"Breast J"},{"key":"10.1016\/j.clinimag.2018.06.010_bb0060","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1148\/radiol.12112669","article-title":"Effect of aromatase inhibitors on background parenchymal enhancement and amount of fibroglandular tissue at breast MR imaging","volume":"264","author":"King","year":"2012","journal-title":"Radiology"},{"key":"10.1016\/j.clinimag.2018.06.010_bb0065","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1148\/radiol.13131198","article-title":"Effects of tamoxifen and aromatase inhibitors on breast tissue enhancement in dynamic contrast-enhanced breast MR imaging: a longitudinal intraindividual cohort study","volume":"271","author":"Schrading","year":"2014","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.clinimag.2018.06.010_bb0070","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1148\/radiol.11102156","article-title":"Background parenchymal enhancement at breast MR imaging and breast cancer risk","volume":"260","author":"King","year":"2011","journal-title":"Radiology"},{"key":"10.1016\/j.clinimag.2018.06.010_bb0075","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1148\/radiol.2015142304","article-title":"Are qualitative assessments of background parenchymal enhancement, amount of fibroglandular tissue on MR images, and mammographic density associated with breast cancer risk?","volume":"276","author":"Dontchos","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.clinimag.2018.06.010_bb0080","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1200\/JCO.2009.27.5933","article-title":"Is mammographic breast density a breast cancer risk factor in women with BRCA mutations?","volume":"28","author":"Passaperuma","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clinimag.2018.06.010_bb0085","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13058-015-0604-1","article-title":"Mammographic density and breast cancer in women from high risk families","volume":"17","author":"Ram\u00f3n","year":"2015","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.clinimag.2018.06.010_bb0090","first-page":"549","article-title":"A dedicated follow-up clinic for BRCA mutation carriers","volume":"18","author":"Yerushalmi","year":"2016","journal-title":"IMAJ"},{"key":"10.1016\/j.clinimag.2018.06.010_bb0095","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1200\/JCO.2008.16.6231","article-title":"Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer","volume":"26","author":"Atchley","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clinimag.2018.06.010_bb0100","doi-asserted-by":"crossref","first-page":"920","DOI":"10.2214\/AJR.16.16957","article-title":"Association of BRCA mutation types, imaging features, and pathologic findings in patients with breast Cancer with BRCA1 and BRCA2 mutations","volume":"209","author":"Ha","year":"2017","journal-title":"AJR"},{"key":"10.1016\/j.clinimag.2018.06.010_bb0105","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1200\/JCO.2002.09.023","article-title":"The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2","volume":"20","author":"Lakhani","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clinimag.2018.06.010_bb0110","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1148\/radiol.2016160284","article-title":"Comparison of parenchymal enhancement at contrast-enhanced spectral mammography and breast MR imaging","volume":"282","author":"Sogani","year":"2017","journal-title":"Radiology"},{"key":"10.1016\/j.clinimag.2018.06.010_bb0115","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1148\/radiol.2017170811","article-title":"Effect of background parenchymal enhancement on breast MR imaging interpretive performance in community-based practices","volume":"286","author":"Ray","year":"2018","journal-title":"Radiology"}],"container-title":["Clinical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899707118301797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899707118301797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:42:19Z","timestamp":1760269339000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0899707118301797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":23,"alternative-id":["S0899707118301797"],"URL":"https:\/\/doi.org\/10.1016\/j.clinimag.2018.06.010","relation":{},"ISSN":["0899-7071"],"issn-type":[{"value":"0899-7071","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of background parenchymal enhancement and fibroglandular density at breast magnetic resonance imaging between BRCA gene mutation carriers and non-carriers","name":"articletitle","label":"Article Title"},{"value":"Clinical Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinimag.2018.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}